B. Glass

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study.

U. Salmenniemi, E. Forcade, Z. Perić, 2023, Bone marrow transplantation.

Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor

E. Forcade, H. Finel, A. Boumendil, 2024, Bone marrow transplantation.

Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis in HLA-matched and haploidentical donor transplants for patients with Hodgkin lymphoma: a comparative study of the LWP EBMT.: GVHD prophylaxis for patients with Hodgkin lymphoma.

J. Pérez-Simón, L. Castagna, A. Dominietto, 2023, Transplantation and cellular therapy.